Clinical trials
Phase 1 Parkinson Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
385 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 8 |
| 2006 | 8 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 20 |
| 2010 | 10 |
| 2011 | 14 |
| 2012 | 12 |
| 2013 | 15 |
| 2014 | 25 |
| 2015 | 16 |
| 2016 | 13 |
| 2017 | 17 |
| 2018 | 22 |
| 2019 | 28 |
| 2020 | 22 |
| 2021 | 17 |
| 2022 | 21 |
| 2023 | 19 |
| 2024 | 21 |
| 2025 | 23 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 251 |
| Recruiting | 44 |
| Unknown status | 30 |
| Terminated | 21 |
| Not yet recruiting | 15 |
| Withdrawn | 14 |
| Active, not recruiting | 8 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bial - Portela C S.A. | 44 |
| Luye Pharma Group Ltd. | 11 |
| Institute for Neurodegenerative Disorders | 10 |
| H. Lundbeck A/S | 9 |
| MODAG GmbH | 6 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 6 |
| NeuroDerm Ltd. | 6 |
| University of Minnesota | 6 |
| AbbVie | 5 |
| Affiris AG | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 385 |
| Alzheimer Disease | 17 |
| Multiple System Atrophy | 17 |
| Movement Disorders | 12 |
| Parkinsonian Disorders | 11 |
| Neurodegenerative Diseases | 10 |
| Dyskinesias | 7 |
| Tauopathies | 7 |
| Cognitive Dysfunction | 6 |
| Lewy Body Disease | 6 |
Trials
Showing 26 to 50 of 385. Each trial links to its page on Pharma Observatory.
285 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.